Buy Crypto Markets Spot FuturesUNITREE Earn Event Centre Rewards Hub

Starling Oncology, Inc. (STLN)

NASDAQ

$6,65

$+1,68

(+33,67%)

Starling Oncology, Inc. (STLN) Live Price Chart

Last updated: ⁦2026-08-07 16:47:20⁩. Stock price data is sourced from Massive.

Key Market Data

Market Cap	$502,91M
Open	$6,53
High	$7,04
Low	$4,85
Previous Close	$4,99
Price Change	$+1,68
Percentage Change	+33,67%
Volume	5M

Starling Oncology, Inc. (STLN) Stock Price Today

Starling Oncology, Inc. (STLN) is currently trading at $6,65 as of 2026-08-07 16:46:00, reflecting a +33,67% move ($+1,68) from the previous close.

In the short term, the stock has returned +28,53% over the past four weeks. Over the last 12 months, Starling Oncology, Inc. has recorded a +28,53% price change, indicating a Strong performance relative to the broader market.

Starling Oncology, Inc. (STLN) 7-Day Stock Price Changes

Over the past seven days, Starling Oncology, Inc. has traded within a short-term range shaped by market sentiment in the sector. During this period, the stock moved from its previous closing price of $5,24 to the latest recorded price of $6,65, reflecting an intraday change of +33,67%. Daily movements highlight shifts in trading volume (4.508.828), investor positioning, and reactions to macroeconomic updates.

From a momentum standpoint, STLN has delivered a +28,53% return over the past month and a +28,53% change in the last 12 months, indicating a Strong trend relative to its broader sector peers.

How to Buy Starling Oncology, Inc. (STLN)

You can buy and trade STLN on MEXC in three simple steps:

Step 1: Create and Verify Your MEXC Account

Sign up on MEXC and complete the required identity verification (KYC). This ensures full access to trading features and secure funding options.

Step 2: Deposit Funds Into Your Account

Choose your preferred payment method to add USDT or other supported assets to your MEXC wallet. Depositing crypto is the fastest way to get started.

Step 3: Search for STLN and Execute Your Trade

Open the trading page, enter STLN in the search bar, select the amount of STLN you would like to purchase. Place a market order for instant execution or a limit order to buy at your target price.

What is Starling Oncology, Inc. (STLN)?

Starling Oncology Inc provides oncology care services in community settings. Its services include cancer diagnosis and treatment, clinical trials, transfusion services, and other oncology care delivery models for patients.

Starling Oncology, Inc. Information

Industry	--
Employees	641
Sector	--
Company Website	https://www.starlingoncology.com

Frequently Asked Questions (FAQ)

1.What is the current share price of Starling Oncology, Inc.?

The latest trading price for Starling Oncology, Inc. (Common Stock) is $ 6,65, compared with a previous closing price of $ 4,99. That means the stock has moved +33,67% so far today. Intraday price updates and recent trading activity for STLN can be tracked on the live chart and quote section on this page.

2.Is Starling Oncology, Inc. stock going up or down?

Looking at recent performances, STLN has returned +28,53% over the past month, +28,53% over the last six months and +28,53% over the past year. These figures capture share-price changes only, not the impact of dividends. Together they describe Strong price momentum for Starling Oncology, Inc. stock, but keep in mind that past returns do not guarantee future results.

3.Where does STLN currently sit relative to its 52-week high and low?

In the most recent 52-week period, Starling Oncology, Inc. has traded between a low of $ 4,85 and a high of $ 7,04. This 52-week range helps show where today's share price sits relative to its recent highs and lows, and is often used by investors to judge stock volatility, potential support and resistance levels, and whether STLN is currently nearer the top or the bottom of its one-year trading band.

4.How is Starling Oncology, Inc. classified by sector and industry?

Starling Oncology, Inc. is classified in the -- sector. In practice, this means Starling Oncology, Inc. is grouped with other companies that serve similar end-markets and operate under comparable competitive and regulatory conditions. For investors, knowing STLN’s sector helps with portfolio diversification, peer comparisons, and understanding how broader trends affecting the -- sector could influence Starling Oncology, Inc.’s performance.

5.Where is Starling Oncology, Inc. listed and how large is it by market value?

Starling Oncology, Inc. is listed on the NASDAQ stock exchange in United States. Based on a market capitalisation of $ 502,91M, the company is classified as a Small-cap stock. Market cap gives a quick sense of Starling Oncology, Inc.'s size and importance in the equity market and is often used by investors and index providers when constructing portfolios or benchmarks.

6.What does STLN's EPS tell investors about its profitability?

Trailing-twelve-month EPS of -- summarises how much profit Starling Oncology, Inc. has generated per share over the last year. Rising EPS over time can signal improving profitability or effective share repurchases, while flat or declining EPS may point to slower growth or margin pressure. EPS is a key input into valuation metrics such as P/E and is often monitored closely around earnings announcements.

7.How can I track Starling Oncology, Inc.'s financial performance over time?

To follow Starling Oncology, Inc.'s financial performance, investors typically review its quarterly and annual reports, which include detailed income statements, balance sheets and cash-flow statements. Combining these filings with key market data shown on this page—such as share price trends, P/E and dividend yield—provides a more complete view of how STLN is performing and how the market is responding.

8.When is Starling Oncology, Inc. expected to report earnings?

Starling Oncology, Inc.'s next scheduled earnings release is currently expected on -- (the date may be updated by the company). Earnings announcements often act as important catalysts for STLN, as they provide updated information on revenue, profitability and management's outlook.

9.What usually comes out in Starling Oncology, Inc.'s earnings reports?

Starling Oncology, Inc.'s earnings reports typically include headline figures such as revenue, net income and EPS, along with commentary on segment performance, margins, cash flow and guidance for future periods. Investors compare these results with market expectations and prior periods to assess whether STLN is meeting, beating or missing expectations.

10.How can I stay informed about Starling Oncology, Inc.'s results and guidance?

You can stay up to date on Starling Oncology, Inc. by reviewing its quarterly earnings releases, listening to or reading transcripts of earnings calls, and following company news and filings. Pairing this fundamental information with the price and return data for STLN on this page helps you see how new information is being reflected in the stock.

11.Does Starling Oncology, Inc. pay a regular cash dividend to its shareholders?

Starling Oncology, Inc. Non-paying. Based on the latest information, the stock has an indicated annual cash dividend of -- per share and a current dividend yield of -- at the recent share price. Dividends are typically paid --, although the board can change the dividend policy at any time. Income-focused investors often monitor STLN's dividend level, payment frequency and any announcements about future dividends when assessing the stock's appeal as a dividend-paying investment.

12.What are the current dividend yield and dividend payout ratio for STLN?

Based on the latest earnings data, STLN has a dividend yield of -- and a dividend payout ratio of --. The dividend yield shows how much cash return an investor receives from dividends each year relative to the current share price, helping assess whether Starling Oncology, Inc. is an attractive income stock. The dividend payout ratio measures what percentage of earnings Starling Oncology, Inc. distributes to shareholders as dividends versus how much it retains to reinvest in the business, which is an important indicator of dividend sustainability and room for future dividend growth.

13.What kind of business is Starling Oncology, Inc.?

Starling Oncology, Inc. is a publicly traded company in the -- industry within the -- sector. It generates revenue from products and services related to this core business area, and investors can find a detailed description of its operations, strategy and geographic exposure in the company's annual report and other regulatory filings.

14.How is STLN valued in terms of P/E ratio and EPS?

Starling Oncology, Inc. currently trades at a price-to-earnings (P/E) ratio of --, based on trailing-twelve-month earnings per share (EPS) of --. P/E is calculated by dividing the share price by EPS and shows how much investors are paying today for each unit of Starling Oncology, Inc.'s earnings. Comparing STLN's P/E and EPS to those of other -- companies can help investors judge whether its valuation looks rich or attractive.

Explore More US Stocks

Largest Market Cap

See US stocks with the highest market capitalisation

Most Actively Traded

Discover today's most actively traded US stocks

Amphenol Corporation

APH

Toronto Dominion Bank

Top Gainers

Browse today's leading gainers in the US stock market

MasterBeef Group

INNOVATE Corp.

VATE

Big Tree Cloud Holdings Limited

DSY

Top 5 Cryptocurrencies

Explore the cryptocurrencies with the highest market capitalisation

BTC

ETH

SOL

Disclaimer

The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.

STLN-to-USD Calculator

Amount

STLN

USD

1 STLN = 6,645 USD